Recruiting Alzheimers Disease Studies in Stamford
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Alzheimer's Disease. The primary objective of the st...
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the...
VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease
This study is to be conducted in participants with early Alzheimer's Disease to test VY7523, a new drug being researched for treatment of Alzheimer's Disease. This study will look at how safe the drug...
About Alzheimers Disease Clinical Trials in Stamford
Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.
There are currently 3 alzheimers disease clinical trials recruiting participants in Stamford, CONNECTICUT. These studies are seeking a combined 807 participants. Research is being sponsored by Karuna Therapeutics, Suven Life Sciences Limited, Voyager Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alzheimers Disease Clinical Trials in Stamford — FAQ
Are there alzheimers disease clinical trials in Stamford?
Yes, there are 3 alzheimers disease clinical trials currently recruiting in Stamford, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stamford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stamford research site will contact you about next steps.
Are clinical trials in Stamford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stamford studies also compensate for your time and travel.
What alzheimers disease treatments are being tested?
The 3 active trials in Stamford are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.
Data updated March 2, 2026 from ClinicalTrials.gov